专注于finerenone:FINEARTS-HF研究的研究
Stefano Tolone1, Maria Denitza Tinti2, Giovanni Pulignano1
1UOC Cardiology, Cardio-Thoracic-Vascular Department, San Camillo Forlanini Hospital, Rome, Italy.
概括
矿物质皮质类受体抗剂 (MRAs),如芬,可显著降低心力衰竭事件,在患者中轻微减少或保留射出分数. 这项研究强调了fineerenone.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 矿物质皮质类受体 (MR) 阻塞是心力衰竭的标准,减少排泄率 (HFrEF).
- 对于轻微减少喷射率 (HFmrEF) 和保存喷射率 (HFpEF) 的心力衰竭,MR阻塞的益处不太明显.
- 之前的研究,如TOPCAT,在这些HF亚型中显示出有限的疗效.
研究的目的:
- 在患有HFmrEF或HFpEF的患者中评估非类固醇MR抗剂finerenone的疗效和安全性.
- 评估芬瑞龙对心血管死亡和恶化的心力衰竭 (WHF) 事件的影响.
主要方法:
- 在FINEARTS-HF研究中,纳入了患有HFmrEF或HFpEF的患者.
- 参与者接受了非类固醇MR抗剂finerenone.
- 主要终点是心血管死亡和WHF事件的复合.
主要成果:
- 费内伦显著降低了初级复合终点,主要是由于总WHF事件的减少.
- 在整个左心室喷射分数 (LVEF) 谱中,疗效一致.
- 无论同时使用的疗法 (例如,SGLT2抑制剂),性别或年龄,都观察到益处,早期发病.
结论:
- 非类固醇MR抗剂芬龙在减少HFmrEF和HFpEF患者心力衰竭事件方面表现出显著的疗效.
- 菲内伦具有良好的安全性和耐受性.
- 这些发现支持finerenone作为一种潜在的新疗法选择,用于更广泛的心力衰竭患者.
相关概念视频
01:11Renal Failure: Dose Adjustments
35
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
35
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
01:22Heart Failure Drugs: Diuretics
282
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
282
01:17Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
440
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
440